Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)
|
May 6, 2008
Newer combination therapies in the management of hypertension: an update
Alan H Gradman, Matthew R Weir, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 13, 2004
Combination angiotensin receptor blocker/hydrochlorothiazide as initial therapy in the treatment of patients with severe hypertension
Christina M Salerno, Laura Demopoulos, Robin Mukherjee, et al.
Quality Management in Health Care
|
September 10, 2004
Reducing radiocontrast use in the cardiac catheterization laboratory--a behavioral modification approach
Azimuddin Tareq Khawaja, Venkatraman Srinivasan, Zafir Hawa, et al.
The Journal of Invasive Cardiology
|
January 5, 2002
Left anterior descending coronary artery to right ventricular fistula complicating coronary stenting
Denes Korpas, Celso Acevedo, Richard L Lindsey, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 4, 2011
Combination therapy in hypertension
Alan H Gradman, Jan N Basile, Barry L Carter, et al.
Journal of the American Society of Hypertension : JASH
|
April 9, 2010
Combination therapy in hypertension
Alan H Gradman, Jan N Basile, Barry L Carter, et al.
Clinical Cardiology
|
July 2, 2009
Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention
Sandeep Arora, Fadi Alfayoumi, Azimuddin Tareq Khawaja, et al.
The Canadian Journal of Cardiology
|
June 16, 2004
Hepatitis C virus-associated pericardial effusion and tamponade in a liver transplant recipient
Lazaros A Nikolaidis, Maher Azzouz, Lois Friedlander, et al.
Clinical Therapeutics
|
August 17, 2002
A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension
Alan H Gradman, William E Brady, Lisa P Gazdick, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 28, 2012
Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study
Alan H Gradman, Hélène Parisé, Patrick Lefebvre, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Journal of Clinical Hypertension (Greenwich, Conn.)
|
May 6, 2008
Newer combination therapies in the management of hypertension: an update
Alan H Gradman, Matthew R Weir, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 13, 2004
Combination angiotensin receptor blocker/hydrochlorothiazide as initial therapy in the treatment of patients with severe hypertension
Christina M Salerno, Laura Demopoulos, Robin Mukherjee, et al.
Quality Management in Health Care
|
September 10, 2004
Reducing radiocontrast use in the cardiac catheterization laboratory--a behavioral modification approach
Azimuddin Tareq Khawaja, Venkatraman Srinivasan, Zafir Hawa, et al.
The Journal of Invasive Cardiology
|
January 5, 2002
Left anterior descending coronary artery to right ventricular fistula complicating coronary stenting
Denes Korpas, Celso Acevedo, Richard L Lindsey, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 4, 2011
Combination therapy in hypertension
Alan H Gradman, Jan N Basile, Barry L Carter, et al.
Journal of the American Society of Hypertension : JASH
|
April 9, 2010
Combination therapy in hypertension
Alan H Gradman, Jan N Basile, Barry L Carter, et al.
Clinical Cardiology
|
July 2, 2009
Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention
Sandeep Arora, Fadi Alfayoumi, Azimuddin Tareq Khawaja, et al.
The Canadian Journal of Cardiology
|
June 16, 2004
Hepatitis C virus-associated pericardial effusion and tamponade in a liver transplant recipient
Lazaros A Nikolaidis, Maher Azzouz, Lois Friedlander, et al.
Clinical Therapeutics
|
August 17, 2002
A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension
Alan H Gradman, William E Brady, Lisa P Gazdick, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 28, 2012
Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study
Alan H Gradman, Hélène Parisé, Patrick Lefebvre, et al.
Page
of 5